On 27 July 2015, UCI announced that Taborre had tested positive for the
HIF prolyl-hydroxylase inhibitor FG-4592 in an out-of-competition control 16 June 2015, and that he was provisionally suspended. It was announced on 25 May 2016 that Taborre would be suspended for four years for the latter infraction, backdated to 26 July 2015. ==Major results==